BEYOND SYMPTOM CONTROL Developing therapies to help people with orphan conditions of the brain and nervous system live their lives to the fullest. Who We Are Noema Pharma is a biotech company developing groundbreaking therapies to address the most debilitating symptoms in orphan conditions of th ...
Location: Switzerland, Basel-City, Basel
Employees: 11-50
Total raised: $173.56M
Founded date: 2020
Investors 4
| Date | Name | Website |
| 07.04.2021 | Sofinnova ... | sofinnovap... |
| 09.05.2023 | Jeito Capi... | jeito.life |
| - | Gilde Heal... | gildehealt... |
| - | Forbion | forbion.co... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 07.03.2023 | Series B | $112M | - |
| 20.12.2020 | Series A | $61.56M | - |
Mentions in press and media 18
| Date | Title | Description | Source |
| 25.04.2024 | 10 Swiss startups to watch in 2024 | Although Switzerland's startup ecosystem might not be the largest in Europe, it is widely recognized... | tech.eu/20... |
| 07.08.2023 | European tech companies are leading the fight against debili... | Did you know that chronic pain affects more than 1.5 billion people worldwide? Chronic and regular e... | tech.eu/20... |
| 04.07.2023 | New executives to drive Life sciences and Fintech startups o... | startuptic... | |
| 10.04.2023 | Il mercato del Venture Capital a marzo 2023 | Come è andato il mercato del Venture Capital a marzo 2023? Come sempre partiamo dai dati per poi pas... | startup-ne... |
| 07.03.2023 | Swiss biotech company Noema Pharma secures €103M to advance ... | Basel, Switzerland-based Noema Pharma, a clinical-stage biotech company, announced on Tuesday that i... | siliconcan... |
| 07.03.2023 | Noema Pharma raises CHF103 million | startuptic... | |
| 07.03.2023 | Forbion co-leads CHF 103 million investment in Noema Pharma | Naarden, The Netherlands – 07 March 2023 – Forbion, a leading European life sciences venture capital... | forbion.co... |
| 07.03.2023 | Noema Pharma Raises CHF 103 Million (USD 112 Million) in Ser... | - | globenewsw... |
| 07.03.2023 | Noema Pharma Raises USD112M in Series B Financing | Noema Pharma, a Basel, Switzerland-based clinical-stage biotech company targeting debilitating centr... | finsmes.co... |
| 18.10.2022 | Noema Pharma Receives FDA Fast Track Designation for basimgl... | BASEL, Switzerland, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Noema Pharma, a clinical-stage biotech company... | globenewsw... |
Show more